Strata Skin Sciences Inc./$SSKN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Strata Skin Sciences Inc.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.
Ticker
$SSKN
Sector
Primary listing
Industry
Health Care Equipment & Supplies
Headquarters
Employees
106
ISIN
US86272A3059
Website
SSKN Metrics
BasicAdvanced
$9.6M
-
-$2.30
-
-
Price and volume
Market cap
$9.6M
52-week high
$2.96
52-week low
$2.10
Average daily volume
11K
Financial strength
Current ratio
1.049
Quick ratio
0.761
Long term debt to equity
601.948
Total debt to equity
614.35
Interest coverage (TTM)
-2.18%
Profitability
EBITDA (TTM)
0.419
Gross margin (TTM)
58.44%
Net profit margin (TTM)
-27.22%
Operating margin (TTM)
-13.44%
Effective tax rate (TTM)
1.82%
Revenue per employee (TTM)
$320,000
Management effectiveness
Return on assets (TTM)
-7.60%
Return on equity (TTM)
-151.23%
Valuation
Price to revenue (TTM)
0.273
Price to book
3.61
Price to tangible book (TTM)
-1.99
Price to free cash flow (TTM)
-13.741
Free cash flow yield (TTM)
-7.28%
Free cash flow per share (TTM)
-16.81%
Growth
Revenue change (TTM)
3.30%
Earnings per share change (TTM)
-29.13%
3-year revenue growth (CAGR)
2.53%
10-year revenue growth (CAGR)
43.65%
3-year earnings per share growth (CAGR)
41.42%
10-year earnings per share growth (CAGR)
-33.43%
SSKN News
AllArticlesVideos

STRATA Skin Sciences Reports First Quarter 2025 Financial Results and Provides a Corporate Update
GlobeNewsWire·1 month ago

STRATA Skin Sciences to Participate in the D. Boral Capital Inaugural Global Conference
GlobeNewsWire·1 month ago

STRATA Skin Sciences to Report First Quarter 2025 Financial Results on May 14, 2025 and Provide Corporate Update
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Strata Skin Sciences Inc. stock?
Strata Skin Sciences Inc. (SSKN) has a market cap of $9.6M as of June 22, 2025.
What is the P/E ratio for Strata Skin Sciences Inc. stock?
The price to earnings (P/E) ratio for Strata Skin Sciences Inc. (SSKN) stock is 0 as of June 22, 2025.
Does Strata Skin Sciences Inc. stock pay dividends?
No, Strata Skin Sciences Inc. (SSKN) stock does not pay dividends to its shareholders as of June 22, 2025.
When is the next Strata Skin Sciences Inc. dividend payment date?
Strata Skin Sciences Inc. (SSKN) stock does not pay dividends to its shareholders.
What is the beta indicator for Strata Skin Sciences Inc.?
Strata Skin Sciences Inc. (SSKN) does not currently have a Beta indicator.